Intelligence Β· INN Directory
Pharmaceutical Drugs
Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.
- Drugs indexed
- 3,187
- Companies
- 1,062
- Pipeline programs
- 18,156
Quick answer
NovaPharmaNews tracks 3,187 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse AβZ for competitive intelligence and medical affairs reference.
-
lasmiditan
RAYVOW
N02CC08 -
lasmiditan succinate
REYVOW
-
latanoprost
CATIOLANZE
S01EE01 -
latanoprost / netarsudil
ROCLANDA
S01EE -
latanoprostene bunod
LATANOPROSTENE BUNOD
-
lazertinib
LAZCLUZE
L01EB09 -
lazertinib mesylate
LAZCLUZE
-
lebrikizumab
EBGLYSS S.A.
D11AH10 -
lebrikizumab-lbkz
EBGLYSS
-
lecanemab
LEQEMBI
N06DX04 -
lecanemab-irmb
LEQEMBI
-
ledipasvir
HARVONI
-
ledispavir
HARVONI
J05AX65 -
lefamulin
XENLETA
J01XX -
lefamulin acetate
XENLETA
-
leflunomide
ARAVA Teva Pharma GmbH
L04AK01 -
lemborexant
DAYVIGO
-
lenacapavir
SUNLENCA
J05AX31 -
lenacapavir sodium
SUNLENCA
-
lenalidomide
LENALIDOMIDE CELGENE EUROPE Amneal Pharma Europe Ltd
L04AX07 -
leniolisib phosphate
JOENJA
-
lenvatinib
KISPLYX
L01XE29 -
lenvatinib mesylate
LENVIMA
-
lerodalcibep-liga
LEROCHOL
Frequently asked questions
What is the NovaPharmaNews drugs directory?
It is a searchable index of 3,187 pharmaceutical active ingredients and their marketed profiles β INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.
Where does drug approval data come from?
Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.
How do I find a drug by brand name?
Use the search box on this page β it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.
Data attribution and licensing: Data sources